Understanding Gout:
How It Develops and
How to Support Gout Prevention
Gout is a form of inflammatory arthritis caused by the deposition of monosodium urate (MSU) crystals in and around joints. It most commonly affects the big toe, but the ankles, knees, feet, fingers and other joints can also be affected.
Although gout is often associated with diet, its development is more complex. Genetics, kidney function, metabolic health, medications, alcohol intake, dietary patterns and the body's ability to produce and eliminate uric acid can all influence an individual's risk.
Understanding the process of gout formation is important because prevention is not simply about avoiding certain foods. The long-term goal is to keep serum urate sufficiently low to prevent the formation and accumulation of urate crystals.
5 Oct, 2026
How Does Gout Form?
1. Purines are broken down into uric acid
Purines are naturally occurring compounds found in human cells and in many foods. When purines are metabolized, they eventually produce uric acid.
The body normally maintains uric acid within a relatively stable range through a balance between:
-
Uric acid production
-
Kidney excretion
-
Intestinal excretion
In most people with hyperuricemia, the major problem is insufficient urate excretion, particularly through the kidneys, rather than simply excessive production.
2. Serum urate becomes too high
When uric acid accumulates in the bloodstream, the condition is called hyperuricemia.
Importantly, hyperuricemia does not automatically mean that a person has gout. Some people have elevated serum urate for years without developing clinical gout. However, persistent hyperuricemia increases the opportunity for urate crystals to form.
3. Urate reaches a supersaturated state
When serum urate remains sufficiently high, body fluids can become supersaturated with urate.
At this point, monosodium urate crystals can begin to form, particularly in tissues where conditions favor crystallization. Temperature, pH and characteristics of local connective tissue can influence crystal formation.
This explains why gout frequently affects peripheral joints such as the big toe.
4. Urate crystals accumulate in the joint
MSU crystals can deposit in cartilage, synovial tissue and other structures surrounding a joint.
The presence of crystals does not necessarily cause immediate symptoms. A person may have substantial urate crystal deposition before experiencing their first recognizable gout attack.
Over time, persistent crystal deposition can contribute to recurrent inflammation and, in more advanced disease, the development of tophi and structural joint damage.
5. The immune system reacts to the crystals
When the immune system detects MSU crystals, it can activate inflammatory pathways.
A particularly important pathway involves the NLRP3 inflammasome, which contributes to production of interleukin-1β (IL-1β) and other inflammatory mediators. This produces the characteristic features of an acute gout attack:
-
Sudden severe joint pain
-
Swelling
-
Redness
-
Warmth
-
Tenderness
-
Reduced joint movement
This is why gout pain can appear extremely suddenly and become severe within a relatively short period.
Why Do Gout Attacks Keep Coming Back?
A gout attack can settle down even though the underlying urate problem remains.
This is an important distinction.
A flare stopping does not necessarily mean the urate crystals have disappeared.
If serum urate remains above the level at which crystals can persist, existing deposits can remain in the tissues and new crystals may continue to form. This creates the possibility of another inflammatory attack later.
Over the long term, maintaining serum urate below the crystallization threshold can progressively reduce the body's urate crystal burden. This is the basis of the treat-to-target approach to gout management.
Gout Prevention: What Can Actually Help?
Gout prevention has several components. Lifestyle measures are important, but people with established gout may also require medical urate-lowering treatment.
1. Maintain a healthy serum urate level
For people who require urate-lowering therapy, the American College of Rheumatology (ACR) recommends a treat-to-target approach, using serial serum urate measurements to guide treatment.
The ACR recommends a target serum urate of:
<6 mg/dL (360 µmol/L)
for patients receiving urate-lowering therapy.
For patients with tophaceous gout or more severe disease, clinicians may consider lower targets depending on the individual clinical situation.
This is important because gout prevention is fundamentally about preventing and gradually removing urate crystal deposits, rather than simply treating pain when an attack occurs.
2. Maintain a healthy body weight
Excess body weight and metabolic abnormalities are associated with higher serum urate and increased gout risk.
Gradual, sustainable weight management may therefore be beneficial.
However, extreme fasting or rapid weight loss is generally not a good strategy for people concerned about gout, because major metabolic changes can temporarily affect uric acid levels.
A better approach is:
Balanced nutrition + regular physical activity + gradual weight management
3. Limit high-purine animal foods
Some foods contain high concentrations of purines and can contribute to increased uric acid production.
Foods commonly recommended for limitation include:
-
Organ meats such as liver and kidney
-
Certain seafood
-
Some types of meat
-
Large quantities of meat-based broths or extracts
Diet should be viewed as one component of gout management rather than the sole cause of the disease. The ACR guideline emphasizes overall dietary and lifestyle management alongside appropriate medical therapy.
4. Reduce sugary beverages
Sugar-sweetened beverages, particularly those containing substantial
amounts of fructose, can contribute to increased uric acid production.
For people concerned about gout, replacing:
Sugary soda → Water / unsweetened beverages
is a practical dietary change.
This is particularly useful because reducing sugary drinks can simultaneously support weight management and overall metabolic health.
5. Limit alcohol, especially beer
Alcohol can increase gout risk through several mechanisms, including effects on urate production and excretion.
Beer is particularly relevant because it contains both alcohol and purine-related compounds.
Therefore, people with recurrent gout may benefit from reducing or avoiding alcohol, particularly during periods of active disease.
6. Stay adequately hydrated
The kidneys play an important role in urate elimination.
Adequate fluid intake supports normal kidney function and urine production. Water is generally the simplest choice for maintaining hydration.
However, hydration alone should not be presented as a treatment that removes established urate crystals.
7. Manage associated health conditions
Gout frequently occurs alongside metabolic and cardiovascular conditions.
Important factors to monitor include:
-
High blood pressure
-
Obesity
-
Type 2 diabetes
-
Chronic kidney disease
-
Dyslipidemia
-
Metabolic syndrome
Addressing these conditions can contribute to overall health and may also help with gout management.
8. Review medications with a healthcare professional
Some medications can affect serum urate.
For example, certain diuretics can increase uric acid levels. Medication changes should never be made independently, but people with recurrent gout can discuss their medication profile with their healthcare professional.
The American College of Rheumatology (ACR) guideline also provides medication-specific recommendations for patients with gout.
Can Supplements Support Gout & Uric Acid Management?
Managing gout and uric acid levels is a long-term process. A comprehensive approach may include healthy dietary habits, regular physical activity, maintaining a healthy weight, adequate hydration and appropriate medical care.
Selected botanical ingredients have been studied for their potential roles in supporting healthy uric acid levels, antioxidant protection, a healthy inflammatory response and joint comfort. As part of a healthy lifestyle, botanical supplementation may provide complementary support for uric acid and joint health.
For people with diagnosed gout, healthcare professionals may recommend evidence-based urate-lowering therapies such as allopurinol or febuxostat, depending on individual circumstances. Treatment is generally guided by monitoring serum urate and working toward an appropriate target level.
Where Botanical Ingredients May Fit
Fructus Terminalia Bellirica
(Bhera Nut) Extract
This ingredient has human clinical research in hyperuricemia and therefore has particular relevance to the uric-acid-support component. It helps to support healthy uric acid level.
Fructus Prunus Cerasus
(Tart Cherry) Extract
Tart cherry contains polyphenols and anthocyanins and has been investigated for its potential effects on serum urate and inflammatory markers.
Semen Apium Graveolens (Celery) Extract
Celery has biological and experimental evidence suggesting potential effects on uric acid metabolism, including pathways related to xanthine oxidase. It helps to support healthy uric acid metabolism.
Resin Boswellia Serrata
(Indian Frankincense) Extract
Boswellia has a different role.
Its clinical research is mainly focused on joint pain, stiffness and physical function. It may therefore complement the formulation by supporting:
-
Joint comfort
-
Mobility
-
Flexibility
-
Healthy inflammatory response
The Gout Management Cycle
A useful way to explain gout prevention is:
High serum urate
↓
Urate supersaturation
↓
MSU crystal formation
↓
Crystal accumulation in joints
↓
Inflammatory response
↓
Gout flare
↓
If urate remains high → crystals persist → recurrent flares
The prevention strategy aims to interrupt this cycle:
Healthy lifestyle + appropriate urate management
↓
Lower serum urate
↓
Reduced crystal formation
↓
Progressive reduction of urate crystal burden
↓
Lower risk of recurrent gout flares
This is why long-term urate management is more important than simply managing pain during individual attacks.
Key Takeaway
Gout is not simply a problem caused by eating one particular food. It is a crystal-deposition disease driven by persistent urate supersaturation.
A comprehensive prevention strategy should therefore focus on:
1. Monitoring serum urate
2. Maintaining a healthy weight
3. Limiting excessive alcohol and sugary drinks
4. Following a balanced dietary pattern
5. Staying adequately hydrated
6. Managing metabolic and kidney health
7. Using urate-lowering therapy as recommended by a healthcare professional
8. Supporting joint health and physical activity
For people living with gout, a comprehensive approach that combines healthy lifestyle habits with botanical support for uric acid and joint health may help support long-term wellbeing. When urate-lowering therapy is recommended, it should be followed under the guidance of a healthcare professional.
References
-
Narang RK, et al. Pathophysiology of gout. Semin Nephrol. 2020 Nov;40(6):550-563.
-
FitzGerald JD, et al. 2020 American College of Rheumatology Guideline for the Management of Gout. Arthritis Care Res (Hoboken). 2020 Jun;72(6):744-760.
-
Usharani P, et al. A randomized, double-blind, placebo-, and positive-controlled clinical pilot study to evaluate the efficacy and tolerability of standardized aqueous extracts of Terminalia chebula and Terminalia bellerica in subjects with hyperuricemia. Clin Pharmacol. 2016 Jun 22:8:51-9.
-
Jäger R, et al. Effects of Tart Cherry Extract Supplementation on Plasma Urate and C-Reactive Protein Levels in Healthy Adults: a Randomized Controlled Trial. J Diet Suppl. 2026;23(1):42-57.
-
Zhang Z, et al. Tart cherry intake and serum uric acid: Meta-analysis of randomized controlled trials and evidence from network pharmacology. Asia Pac J Clin Nutr. 2026 May 18;35(3):451-462.
-
Dolati K, et al. Inhibitory Effects of Apium graveolens on Xanthine Oxidase Activity and Serum Uric Acid Levels in Hyperuricemic Mice. Prev Nutr Food Sci. 2018 Jun;23(2):127-133.
-
Prabhavathi K, et al. A randomized, double blind, placebo controlled, cross over study to evaluate the analgesic activity of Boswellia serrata in healthy volunteers using mechanical pain model. Indian J Pharmacol. 2014 Sep-Oct;46(5):475-9.